Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Troxacitabine in Treating Patients With Chronic Myelogenous Leukemia

This study has been completed.
Information provided by (Responsible Party):
Shire Identifier:
First received: March 3, 2001
Last updated: May 30, 2013
Last verified: May 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: February 2002 (Final data collection date for primary outcome measure)